Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
News Alert: GE Healthcare recalls certain SpO2 sensors due to risk of errors during defibrillation
Friday, July 28, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

READ MORE >
GE Healthcare recall TruSignal SpO2 sensors
Share on Twitter Share on Facebook Share on Linkedin

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

Share on Twitter Share on Facebook Share on Linkedin
GE Healthcare recall TruSignal SpO2 sensors
There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Stroke risk after TAVR | The top hospitals for cardiology, heart surgery & vascular surgery | New SCAI guidelines
Safety issue could lead to a device shortage | New ACC/AHA hypertension guidelines | Gene research links kidney health to CVD
Most popular cardiology video interviews this past month
Week in Review: A big win for Lilly | Heart pump accessories recalled | How Lp(a) tests could transform care | Doc to pay $1.2M
Oral GLP-1 drug impresses | The power of prevention | Cannabis use in older patients | Drinking habits & heart health
News Alert: FDA shares new safety concern with Medtronic catheters
Heart pump accessories recalled | Is it time for universal Lp(a) screening? | Long-term survival after mitral valve surgery

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …61
    • Page 62
    • Page 63
    • Page 64
    • Current page 65
    • Page 66
    • Page 67
    • Page 68
    • Page 69 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup